INDUSTRY NEWS

00.001-BR-May-2021

Real-world data (RWD) will prepare us for the next pandemic

  • Machine-learning techniques within a shared database could generate predictive insights, showing the patterns in communities that precede outbreaks and helping dictate where and when lockdowns and social distancing orders should be implemented
  • For example, Germany is using de-identified tracking apps to identify anomalies in day-to-day habits, such as regularly active users skipping exercising or walks to predict when a community is likely about to experience an outbreak—and prevent it before it worsens
  • The experience of Israel offers a great example of how real-world data can be analyzed and shared. By swiftly rolling out the Pfizer vaccine to more than half its population and tracking the results, the country was able to demonstrate a dramatic decrease in serious infections and hospitalizations as a consequence of the vaccine

Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com

ref: MAY2021BR001